You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

imatinib resistance

Showing 1 - 25 of 8,584
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GIST Trial in Xi'an (Imatinib)

Recruiting
  • GIST
  • Xi'an, Shaanxi, China
    Xijing Hospital of Air Force Military Medical University
Jun 8, 2023

Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

Terminated
Has Results
  • Chronic Phase Chronic Myeloid Leukemia
  • Ponatinib 30 mg QD
  • +2 more
  • Bruxelles, Belgium
    Cliniques Universitaire Saint-Luc (Site 058)
Oct 28, 2021

Clinical Research of Drug Holiday Based on MRD Detection in GIST

Recruiting
  • Gastrointestinal Stromal Tumors
    • Beijing, Beijing, China
      Peking University People's Hospital
    May 11, 2023

    Leukemia Trial in Los Angeles (dasatinib)

    Completed
    • Leukemia
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center at UCLA
    Jul 30, 2020

    Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • San Francisco, California
      University of California, San Francisco
    Dec 6, 2022

    Chronic Myelogenous Leukemia Trial in Beirut (Nilotinib)

    Recruiting
    • Chronic Myelogenous Leukemia
    • Beirut, Lebanon
      American University of Beirut Medical Center
    Feb 14, 2022

    Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)

    Not yet recruiting
    • Gastrointestinal Stromal Tumors
    • Rivoceranib Mesylate, Paclitaxel
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Jun 7, 2023

    GIST: Assessment of Tumor Mutations and TKI Plasma Exposure

    Recruiting
    • Gastro-intestinal Stromal Tumor
    • Vena puncture for blood collection
    • Tumor biopsy
    • Amsterdam, Netherlands
    • +4 more
    May 17, 2022

    Pulmonary Arterial Hypertension Trial in Worldwide (AV-101, Placebo)

    Recruiting
    • Pulmonary Arterial Hypertension
    • Phoenix, Arizona
    • +15 more
    Aug 12, 2022

    Imatinib With Hepatic Resection or Other Local Treatment for

    Completed
    • GIST, Malignant
    • Liver Metastases
    • imatinib (IM)
    • +3 more
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital of Sun Yat-sen University
    Sep 12, 2023

    Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

    Active, not recruiting
    • Chronic Myelogenous Leukemia
    • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
    • Boston, Massachusetts
    • +18 more
    Jan 19, 2023

    Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

    Completed
    • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    • Angers, France
    • +9 more
    Aug 17, 2022

    Oncogenetic Panel and Integrated Clinical Data Registry Study

    Recruiting
    • Gastrointestinal Stromal Tumor (GIST)
      • Changhua, Taiwan
      • +12 more
      Dec 6, 2022

      Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)

      Not yet recruiting
      • Gastrointestinal Stromal Tumors
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 12, 2023

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 15, 2022

      Pulmonary Arterial Hypertension Trial in United Kingdom (Imatinib Mesylate)

      Recruiting
      • Pulmonary Arterial Hypertension
      • Imatinib Mesylate
      • London, Greater London, United Kingdom
      • +7 more
      Sep 17, 2021

      Myeloid Leukemia, Chronic Trial in Germany (dasatinib (SPRYCEL®))

      Active, not recruiting
      • Myeloid Leukemia, Chronic
      • dasatinib (SPRYCEL®)
      • Aachen, Germany
      • +52 more
      Jun 1, 2022

      Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic Trial in France (Imatinib maintenance)

      Recruiting
      • Gastrointestinal Stromal Tumors
      • +4 more
      • Imatinib maintenance
      • Marseille, Bouches Du Rhône, France
      • +16 more
      Jul 28, 2021

      Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

      Completed
      Has Results
      • Chronic Myelogenous Leukemia
      • +3 more
      • Duarte, California
      • +100 more
      Jun 8, 2021

      Gastrointestinal Stromal Tumors Trial in Seoul (PDR001, Imatinib)

      Recruiting
      • Gastrointestinal Stromal Tumors
      • PDR001, Imatinib
      • Seoul, Korea, Republic of
        Asan Medical Center
      Jun 22, 2021

      Gastrointestinal Stromal Tumors (GISTs) Trial in Seoul (Imatinib Mesylate)

      Completed
      • Gastrointestinal Stromal Tumors (GISTs)
      • Imatinib Mesylate
      • Seoul, Korea, Republic of
        Asan Medical Center
      Dec 30, 2022

      EGFR Gene Mutation, Nonsmall Cell Lung Cancer Trial in Washington, Hackensack (Dasatinib, Osimertinib)

      Active, not recruiting
      • EGFR Gene Mutation
      • Nonsmall Cell Lung Cancer
      • Washington, District of Columbia
      • +1 more
      Jan 9, 2022

      Gastro Intestinal Stromal Tumour Trial in France (Lenvatinib, Placebo, Best supportive care)

      Recruiting
      • Gastro Intestinal Stromal Tumour
      • Marseille, Bouches Du Rhône, France
      • +7 more
      Jul 28, 2021

      Pulmonary Arterial Hypertension Trial in Worldwide (Imatinib, Sildenafil, Bosentan)

      Completed
      Has Results
      • Pulmonary Arterial Hypertension
      • Tampa, Florida
      • +10 more
      Jun 17, 2021

      Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)

      No longer available
      • Acute Lymphoblastic Leukemia (ALL)
      • (no location specified)
      Aug 5, 2022